These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 33334862)

  • 21. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 22. Need to promote healthy lifestyle as primary prevention to the COVID-19 and to improve the immune response to vaccines.
    De la Cámara MÁ; Pardos-Sevilla AI; Jiménez-Fuente A; Veiga ÓL
    Acta Biomed; 2020 Nov; 92(1):e2021026. PubMed ID: 33682812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID vaccine immunity is waning - how much does that matter?
    Dolgin E
    Nature; 2021 Sep; 597(7878):606-607. PubMed ID: 34548661
    [No Abstract]   [Full Text] [Related]  

  • 25. China's COVID vaccines have been crucial - now immunity is waning.
    Mallapaty S
    Nature; 2021 Oct; 598(7881):398-399. PubMed ID: 34650240
    [No Abstract]   [Full Text] [Related]  

  • 26. A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2021 Jan; 21(1):2-3. PubMed ID: 33069282
    [No Abstract]   [Full Text] [Related]  

  • 27. How nano can fight the virus.
    Ball P
    Nat Mater; 2021 Feb; 20(2):126. PubMed ID: 33504984
    [No Abstract]   [Full Text] [Related]  

  • 28. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 29. The UK has approved a COVID vaccine - here's what scientists now want to know.
    Ledford H; Cyranoski D; Van Noorden R
    Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One Shot Wonder: A Vaccine Against All Coronaviruses.
    Mertz L
    IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
    Ledford H
    Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
    [No Abstract]   [Full Text] [Related]  

  • 34. Do not repeat mistakes from HIV in COVID-19 response.
    The Lancet Hiv
    Lancet HIV; 2021 Feb; 8(2):e59. PubMed ID: 33493437
    [No Abstract]   [Full Text] [Related]  

  • 35. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
    Griffiths EA; Segal BH
    Cancer Cell; 2021 Aug; 39(8):1045-1047. PubMed ID: 34242573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Spencer EA; Klang E; Dolinger M; Pittman N; Dubinsky MC
    Inflamm Bowel Dis; 2021 Oct; 27(11):1862-1864. PubMed ID: 34427638
    [No Abstract]   [Full Text] [Related]  

  • 39. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals.
    Jordan SC; Shin BH; Gadsden TM; Chu M; Petrosyan A; Le CN; Zabner R; Oft J; Pedraza I; Cheng S; Vo A; Ammerman N; Plummer J; Ge S; Froch M; Berg A; Toyoda M; Zhang R
    Cell Mol Immunol; 2021 Nov; 18(11):2554-2556. PubMed ID: 34531555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.